This is a StreetInsider.com Premium Only Page

Neoleukin Therapeutics (NLTX) – Analyst Ratings

Jan 3, 2023 06:18 AM Guggenheim Downgrades Neoleukin Therapeutics (NLTX) to Neutral

Nov 16, 2022 06:11 AM H.C. Wainwright Downgrades Neoleukin Therapeutics (NLTX) to Neutral

Nov 15, 2022 04:58 AM

Nov 15, 2022 04:01 AM

Nov 15, 2022 03:35 AM

Nov 15, 2022 03:18 AM

Sep 12, 2022 09:16 AM

Jul 6, 2022 07:42 AM

Jan 10, 2022 01:34 PM

Aug 6, 2021 03:44 AM

Jan 5, 2021 04:22 PM

Sep 22, 2020 04:08 PM

Jun 17, 2020 04:07 PM

Apr 13, 2020 07:27 AM

Mar 16, 2020 06:03 AM

Mar 12, 2020 05:25 AM

Feb 18, 2020 06:59 AM

Jan 10, 2020 04:34 AM

Mar 30, 2009 10:22 AM

Aug 7, 2008 12:05 PM